Stanford Peng
InvestorVenture Partner at Frazier Life Sciences · Board director at Alpine Immune Sciences
Seattle
About
Stanford Peng is a Venture Partner at Frazier Life Sciences, where he works on company creation, joining the firm in 2025. A physician-scientist and R&D executive with over 25 years of drug development and biomedical research experience, he most recently served as President and Head of R&D at Alpine Immune Sciences, which was acquired by Vertex Pharmaceuticals. He has previously held roles at Stemcentrx, Seagen, Roche, Benaroya Research Institute, and Washington University in St. Louis, and continues to practice as a rheumatologist.
Invests in
Biotech
Board director at Alpine Immune Sciences
Intro paths
→
In turn, Stanford can intro founders to Alpine Immune Sciences's investors below.
Alpine Immune Sciences's investors · 3
Co-founders at Alpine Immune Sciences
DM
Dr. Mitchell H GoldExecutive Officer, Director
MG
Mitchell GoldExecutive Chairman and Chief Executive Officer
Experience
- Frazier Life SciencesVenture Partnercurrent2025 — present
- Alpine Immune Sciences (acquired by Vertex Pharmaceuticals)President and Head of Research & Development2016 — 2024
- Stemcentrx, Inc. (acquired by Abbvie)Chief Medical Officer2015 — 2016
Skills & more
Lifesciences15Rheumatology31Biomarkers11Immunology53Biotechnology54Clinical Development51Clinical Research70Drug Discovery6Clinical Trials25Molecular Biology8Oncology10Drug Development11
+12 more
Translational ResearchCancerMedicineInfectious DiseasesPharmacologyVirologyMedical WritingNeurosciencePharmaceutical IndustryTeam LeadershipTranslational MedicineBiostatistics- Registered in Musculoskeletal (RMSK) Sonography — American Registry for Diagnostic Medical Sonography
- Internal Medicine — American Board of Internal Medicine
- Rheumatology — American Board of Internal Medicine
- Physician — Medical Board of California
- Physician — Washington State Department of Health
From Stanford's professional profile.
Colleagues at Frazier Life Sciences
Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences
Anna H. Chen
Partner at Frazier Life Sciences
Frequently asked questions
- Who is Stanford Peng?
- Stanford Peng is a Venture Partner at Frazier Life Sciences, where he works on company creation, joining the firm in 2025. A physician-scientist and R&D executive with over 25 years of drug development and biomedical research experience, he most recently served as President and Head of R&D at Alpine Immune Sciences, which was acquired by Vertex Pharmaceuticals. He has previously held roles at Stemcentrx, Seagen, Roche, Benaroya Research Institute, and Washington University in St. Louis, and continues to practice as a rheumatologist.
- Where does Stanford Peng work?
- Stanford Peng is Venture Partner at Frazier Life Sciences and Board director at Alpine Immune Sciences.
- What does Stanford Peng invest in?
- Stanford Peng invests in Biotech.
- Where did Stanford Peng go to school?
- Stanford Peng studied at Brigham and Women's Hospital (Fellowship, Rheumatology); University of Pennsylvania School of Medicine (Residency, Internal Medicine); Yale School of Medicine (MD, PhD).
Same school
Also attended Brigham and Women's Hospital1
Also attended University of Pennsylvania School of Medicine29
René KuijtenInvestor at LSP (Life Sciences Partners)Jun JeonInvestor at Khosla VenturesRené R. KuijtenInvestor at LSP (Life Sciences Partners)Seth GlickmanDigital Health Advisor at Excelerate Health VenturesJonathan LeffExecutive Partner, Private Equity at Sofinnova VenturesAaron NelsonPartner at Novo Holdings
+ 23 more
Also attended Yale School of Medicine33
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpJeffrey LowPartner at Averin CapitalBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMax FarinaPrincipal at 5AM VenturesBrian YordyPrincipal at F-Prime Capital Partners
+ 27 more
Also attended Stanford University2,000
Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital
+ 1,994 more